They made Group EBITDA of $2.2m in July, as shared in the trading update.
July not exactly a big month, with no Easter, Christmas, etc so we can assume growth from there.
We know the transaction value in August exceeded July.
12 x July's EBITDA gives you $26.4m in EBITDA for the year, which is just over the mid-point of guidance ($23m - $29m).
With transaction growth during the year across terminals and online, with Christmas still to come, I can see them exceeding guidance.
Price target by end of year $2.50 for me.
This bid has just made the market wake up again as operating leverage kicks in.
- Forums
- ASX - By Stock
- TYR
- Ann: Tyro Rejects Non-Binding Indicative Proposal
TYR
tyro payments limited
Add to My Watchlist
0.56%
!
89.5¢

Ann: Tyro Rejects Non-Binding Indicative Proposal, page-35
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
89.5¢ |
Change
0.005(0.56%) |
Mkt cap ! $470.2M |
Open | High | Low | Value | Volume |
89.0¢ | 89.5¢ | 89.0¢ | $49.05K | 54.85K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 21727 | 89.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
89.5¢ | 2817 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 12557 | 0.890 |
5 | 4037 | 0.885 |
4 | 26229 | 0.880 |
2 | 7904 | 0.875 |
4 | 23307 | 0.870 |
Price($) | Vol. | No. |
---|---|---|
0.895 | 3733 | 3 |
0.900 | 51641 | 15 |
0.905 | 5344 | 4 |
0.910 | 26138 | 11 |
0.915 | 24353 | 3 |
Last trade - 10.03am 30/06/2025 (20 minute delay) ? |
Featured News
TYR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online